Subject: Growth Hormone (GH) Therapy*. Effective Date: July 29, 2003. Department(s): Utilization Management. Policy: Treatment with GH (HCPCS J2941) is reimbursable under Plans. administered by QualCare, Inc. for the indications listed below. Objective: To provide proper and consistent reimbursement for and to ensure.
Branch and is intended to preserve the role of CRS as a confidential resource. decision whether and how to place individual CRS products in the public domain. congressional publications, or through their own web sites. CRS for individual congressional clients, should be maintained. interpreted broadly.
Whether the attorney informed the expert that their discussions were confidential, whether the expert reviewed materials marked as confidential or attorney work product, whether the expert was asked to sign a confidentiality agreement, the number of discussions held over a period of time, the type of documents reviewed (publically files or confidential), the type of information conveyed to the expert, amount of time involved in discussions or meetings, whether the expert provided the ...